Silver-Russell syndrome (SRS) is a congenital developmental disorder characterized by intrauterine and postnatal growth failure, craniofacial features (including a triangular shaped face and broad forehead), relative macrocephaly, protruding forehead, body asymmetry and feeding difficulties. Hypomethylation of the H19 differentially methylated region (DMR) on chromosome 11p15.5 is the most common cause of the SRS phenotype. We report the first SRS patient with hypomethylation of the H19-DMR and maternally derived 15q11.2-q13.1 duplication. Although her clinical manifestations overlapped with those of previously reported SRS cases, the patient's intellectual disability and facial dysmorphic features were inconsistent with the SRS phenotype. Methylation analyses, array comparative genomic hybridization, and a FISH analysis revealed the hypomethylation of the H19-DMR and a maternally derived interstitial 5.7 Mb duplication at 15q11.2-q13.1 encompassing the Prader-Willi/Angelman critical region in the patient. On the basis of the genetic and clinical findings in the present and previously reported cases, it is unlikely that the 15q duplication in the patient led to the development of hypomethylation of the H19-DMR and it is reasonable to consider that the characteristic phenotype in the patient was caused by the coexistence of the two (epi)genetic conditions. Further studies are needed to clarify the mechanisms leading to methylation aberrations in SRS.
INTRODUCTION
Silver-Russell syndrome (SRS) is a congenital developmental disorder characterized by intrauterine and postnatal growth failure, craniofacial features (including a triangular shaped face and broad forehead), relative macrocephaly, protruding forehead, body asymmetry and feeding difficulties (OMIM 180860). SRS is mainly caused by the hypomethylation of the H19-differentially methylated region (DMR) on chromosome 11p15.5 and maternal uniparental chromosome 7 (upd(7)mat), which account for~40% and 5-10% of SRS patients, respectively. In addition, several other (epi)genetic aberrations, including 14q32 abnormalities, a heterozygous 15q26.3 deletion, and multilocus imprinting disturbance have been identified in a small fraction of SRS-like patients. [1] [2] [3] 15q11.2-q13.1 duplication syndrome is characterized by hypotonia, motor delays, intellectual disability, autism spectrum disorder (ASD) and epilepsy (OMIM 608636). 4 This condition is caused by the presence of at least one extra maternally derived copy of the Prader-Willi/Angelman critical region (PWACR) within chromosome 15q11.2-q13.1, whereas individuals with paternally derived 15q11-q13 duplication are unlikely to develop symptoms. 5, 6 We herein report the clinical and genetic findings in the first SRS patient with a maternally derived 15q11.2-q13.1 duplication, and discuss the relationship between hypomethylation of the H19-DMR and 15q11.2-q13.1 duplication in the patient.
CASE REPORT
A Japanese girl was born at 39 weeks' gestation. At birth, her body length was 37.5 cm (-5.0 s.d.), her body weight was 1.47 kg (-5.0 s.d.) and her occipitofrontal circumference was 34.5 cm (+1.0 s.d.). She was diagnosed with SRS in infancy because the clinical features satisfied five of the six key features in the Netchine-Harbison SRS clinical scoring system (prenatal growth retardation, relative macrocephaly, protruding forehead, body asymmetry and feeding difficulties). 7 She also had dysmorphic facial features (upturned nose, down-slanting palpebral fissures, hypertelorism and low-set ears), which are observed less frequently in patients with SRS (Figures 1a and b ; Table 1 ). She had severe hypotonia and failure to thrive in infancy. Her motor development was obviously delayed; she held up her head at 9 months, rolled over at 10 months, and walked at 2 years and 6 months.
At 9 years of age, treatment with a long-acting gonadotropinreleasing hormone analog was initiated because she entered puberty with severe short stature (−4.8 s.d.); however, the therapy had only modest effects on her growth (Figure 1c Her non-consanguineous parents and elder sister were clinically normal. Her father and mother were 180 cm (+0.6 s.d.) and 152 cm (-1.3 s.d.) tall, respectively. There was no family history of seizure, neurodevelopmental diseases or congenital malformation.
MOLECULAR STUDIES
This study was approved by the Institutional Review Board Committee at the National Center for Child Health and Development. DNA was obtained from peripheral blood samples from the patient and her parents after obtaining written informed consent.
First, we performed pyrosequencing-based methylation analyses for two DMRs responsible for SRS (H19-DMR and PEG1/MEST-DMR on chromosome 7), as previously reported. 8, 9 The results showed profound hypomethylation of the H19-DMR in the patient. Subsequently, we performed methylation analyses for other DMRs related to known imprinting disorders to search for multilocus imprinting disturbance, and found mild hypermethylation of the SNRPN-DMR at 15q11.2 ( Figure 2a and Supplementary  Table 1) .
Because the patient's intellectual disability and facial dysmorphic features were inconsistent with the SRS phenotype, we performed oligoarray comparative genomic hybridization using a human catalog array (2 × 400K format, ID G4448A; Agilent Technologies, Santa Clara, CA, USA) to identify other mechanisms leading to the phenotype. This revealed a 5.7-Mb duplication at 15q11.2-q13.1 encompassing the PWACR (Figure 2b) . The duplication was also identified in the patient's mother. Fluorescence in situ hybridization with an SNRPN probe for PWACR detected two signals with a marked difference in intensity (a normal signal and an intense signal), indicating that this was an interstitial tandem duplication (Figure 2c) . A methylation analysis of the mother revealed mild hypomethylation at the SNRPN-DMR in contrast to the results in the patient (Figure 2a and Supplementary Table 1) .
DISCUSSION
We identified hypomethylation of the H19-DMR and a maternally derived 15q11.2-q13.1 duplication in a patient with SRS. The patient had typical SRS manifestations as well as intellectual disability and dysmorphic facial features, which are common in patients with 15q11.2-q13.1 duplication syndrome, but not in SRS patients (Figure 1 and Table 1 ). [10] [11] [12] These findings imply that the characteristic phenotype in the patient was likely caused by the coexistence of two rare epigenetic and genetic conditions. The genetic basis for the development of H19-DMR hypomethylation in SRS patients remains to be explored. 1, 3 No unambiguous genomic aberrations in patients with hypomethylation of the H19-DMR have been identified thus far. 1, 13, 14 In this regard, it is unlikely that the 15q11.2-q13.1 duplication in the present patient led to the development of hypomethylation of the H19-DMR for the following reasons. First, although over 30 different copy number variations have been reported in patients with the SRS phenotype, 15q11.2-q13.1 duplications have not been reported in SRS patients. 1, [13] [14] [15] Second, although patients with 15q11.2-q13.1 duplication show methylation abnormalities of the SNRPN-DMR, those of the H19-DMR or other DMRs have not been reported in those patients. Third, the major manifestations seen in SRS patients (postnatal growth failure, relative macrocephaly, clinodactyly and body asymmetry) have rarely (or never) been detected in patients with 15q11.2-q13.1 duplications. [10] [11] [12] Taken together, the two rare (epi)genetic conditions seemed to co-exist in the patient by chance. The phenotypically normal mother also had the same 15q duplication. In this regard, since the duplicated region, including the PWACR is imprinted, almost all of the previously reported children who inherit the duplicated allele from their mothers develop symptoms, whereas those who inherit it from their fathers are unlikely to develop symptoms. 6, [10] [11] [12] Hypomethylation at the SNRPN-DMR, which is methylated on the maternal allele, indicates the paternal origin of the duplication in the mother. 3 These findings are consistent with the normal phenotype of the mother.
In conclusion, we reported the first case of H19-DMR hypomethylation and maternally derived interstitial 15q11.2-q13.1 duplication. Further studies are needed to clarify the mechanisms leading to the epimutation in SRS patients. 
